Gsa Capital Partners LLP Xoma Corp Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$15.11 - $28.71 $231,938 - $440,698	-15,350 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$17.5 - $28.66 $74,095 - $121,346	-4,234 Reduced 21.62%	15,350 $419,000
Q3 2019 Nov 12, 2019	SELL	$15.02 - $21.51 $450,885 - $645,708	-30,019 Reduced 60.52%	19,584 $386,000
Q2 2019 Aug 06, 2019	SELL	$11.83 - $18.98 $148,750 - $238,654	-12,574 Reduced 20.22%	49,603 $737,000
Q1 2019 May 15, 2019	BUY	$11.95 - $15.53 $56,905 - $73,953	4,762 Added 8.29%	62,177 $770,000
Q4 2018 Feb 12, 2019	BUY	$11.27 - $17.54 $28,175 - $43,850	2,500 Added 4.55%	57,415 $726,000
Q3 2018 Nov 13, 2018	BUY	$15.67 - $25.73 $416,822 - $684,418	26,600 Added 93.94%	54,915 $965,000
Q2 2018 Aug 09, 2018	BUY	$19.68 - $25.28 $320,784 - $412,064	16,300 Added 135.66%	28,315 $591,000
Q1 2018 May 11, 2018	BUY	$19.86 - $35.92 $238,617 - $431,578	12,015 New	12,015 $243,000

6.5M

100

1.6K

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $338M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.